Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer

Annals of Surgical Oncology

Volumn 22, Issue 11, 2015, Pages 3625-3631

  van Vugt, Jeroen L A ^a   Braam, Hidde J ^a   van Oudheusden, Thijs R ^b   Vestering, Asra ^a   Bollen, Thomas L ^a   Wiezer, Marinus J ^a   de Hingh, Ignace H J T ^b   van Ramshorst, Bert ^a   Boerma, Djamila ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; POSTOPERATIVE COMPLICATION; REOPERATION; SARCOPENIA; SKELETAL MUSCLE; ADVERSE EFFECTS; AGED; COLORECTAL NEOPLASMS; COMPLICATION; MIDDLE AGED; OPERATION DURATION; OPERATIVE BLOOD LOSS; PARENTERAL DRUG ADMINISTRATION; PATHOLOGY; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY; RETROSPECTIVE STUDY; SECONDARY; SEVERITY OF ILLNESS INDEX; THERMOTHERAPY;

ANTINEOPLASTIC AGENT; MITOMYCIN;

AGED; ANTINEOPLASTIC AGENTS; BLOOD LOSS, SURGICAL; COLORECTAL NEOPLASMS; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MITOMYCIN; OPERATIVE TIME; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SARCOPENIA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84941418763     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4429-z     Document Type: Article

References (23)

1. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212–22.
2. Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152–65.
3. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900–7.
4. Baratti D, Kusamura S, Iusco D, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014;57:858–68.
5. Simkens GA, van Oudheusden TR, Luyer MD, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2014. doi:10.1245/s10434-014-4297-y.
6. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–6.
7. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.
8. Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015. doi:10.1245/s10434-014-4281-6.
9. Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261:345–52.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg. 2004;240:205–13.
11. Braam HJ, Boerma D, Wiezer MJ, van Ramshorst B. Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment. Eur J Surg Oncol. 2013;39:988–93.
12. Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ. Quantitative intraoperative assessment of peritoneal carcinomatosis: a comparison of three prognostic tools. Eur J Surg Oncol. 2009;35:1078–84.
13. Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466–77.
14. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.
15. Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB Oxford. 2011;13:439–46.
16. Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901–8.
17. Mak PH, Campbell RC, Irwin MG; American Society of A. The ASA physical status classification: interobserver consistency. American Society of Anesthesiologists. Anaesth Intensive Care. 2002;30:633–40.
18. Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. NatlRev Clin Oncol. 2013;10:90–9.
19. Levolger S, Van Vledder MG, Huisman SA, De Bruin RWF, Ijzermans JNM. Inhibition of ALK 4/5 inhibits cancer cachexia associated muscle wasting. Eur Surg Res. 2014;52:105.
20. Han HQ, Zhou X, Mitch WE, Goldberg AL. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013;45:2333–47.
21. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.
22. Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery. 2014;156:521–7.
23. Chiba F, Soda K, Yamada S, et al. The importance of tissue environment surrounding the tumor on the development of cancer cachexia. Int J Oncol. 2014;44:177–86.